Evidence map›Paper›PMID 42268467›Full record

ArticleDiscover oncology2026

Machine learning for predicting liver metastasis in colorectal cancer.

Yujie Li, Yunwei Wei, Yangjun Li

Abstract read
In one paragraph

Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yujie LiDepartment of General Surgery, Ningbo No.2 Hospital, Wenzhou Medical University, No. 41, Xibei Street, Ningbo, 315010, China.
Yunwei WeiDepartment of General Surgery, Ningbo No.2 Hospital, Wenzhou Medical University, No. 41, Xibei Street, Ningbo, 315010, China.
Yangjun LiDepartment of General Surgery, Ningbo No.2 Hospital, Wenzhou Medical University, No. 41, Xibei Street, Ningbo, 315010, China. liyangjun0713@163.com.

Funding

Key Laboratory of Intestinal Microecology and Major Human Diseases in Ningbo 2023016Ningbo Top Medical and Health Research Program 2022010101The Joint Funds of the National Natural Science Foundation of China U23A20458
6 · The paper itself

Abstract

aimTo evaluate the performance of machine learning models in predicting liver metastasis in colorectal cancer (CRC) patients using the SEER database and external validation from Ningbo No.2 Hospital.

methodsThe data on patients with colorectal cancer were obtained from Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2023. Patients were classified into training (n = 29017) and testing sets (n = 12437). The data were used to build eight machine learning models to predict liver metastasis in colorectal cancer patients. A total of 11 clinical variables were entered into these models. Model performance was measured with the area under the receiver operating characteristic curve (ROC) and area under precision-recall curve (AUPR). The models were visualized and interpreted using the SHAP method.

resultsIn the SEER database cohort, the incidence of liver metastasis was 7.2% (2977/41,454). Of the eight machine learning models, Gradient Boosting (GB) had the best AUC (0.837) and AUPR (0.294). Upon external validation, the GB model achieved an AUC of 0.730 and an AUPR of 0.278. We explored the significance of features in the model through SHAP analysis. CEA, N stage and T stage were the heavily weighted factors used by the GB. An online calculator was developed for clinical use.

conclusionThe GB model demonstrates robust predictive performance for liver metastasis in CRC, validated internally and externally, and presents a potentially valuable tool for clinical decision-making.

Indexed as

Colorectal cancerLiver metastasisMachine learning

Identifiers

PMID42268467
PMCPMC13504058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.